Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Assets
Cash and due from banks	$ 51,026	$ 32,586
Interest-bearing deposits with banks	197,848	32,575
Cash and cash equivalents	248,874	65,161
Restricted investments in bank stocks	20,232	11,992
Securities available-for-sale (amortized cost of $864,920 and $549,089 at December 31, 2024 and 2023, respectively)	829,711	513,519
Loans held for sale, at fair value	6,614	5,816
Loans	3,931,214	2,298,313
Less: Allowance for credit losses	(48,689)	(28,702)
Net loans	3,882,525	2,269,611
Premises and equipment, net	50,217	29,393
Cash surrender value of life insurance	143,854	73,204
Goodwill	68,106	18,724
Other intangible assets, net	47,765	2,414
Accrued interest receivable	21,058	13,630
Deferred tax assets, net	42,647	22,017
Other assets	79,986	38,759
Total assets	5,441,589	3,064,240
Deposits:
Noninterest-bearing	894,176	430,959
Interest-bearing	3,728,920	2,127,855
Total deposits	4,623,096	2,558,814
Securities sold under agreements to repurchase and federal funds purchased	25,863	9,785
FHLB advances and other borrowings	115,364	137,500
Subordinated notes and trust preferred debt	68,680	32,093
Other liabilities	91,904	60,992
Total liabilities	4,924,907	2,799,184
Shareholders’ Equity
Preferred stock, $1.25 par value per share; 500,000 shares authorized; no shares issued or outstanding	0	0
Common stock, no par value—$0.05205 stated value per share 50,000,000 shares authorized; 19,722,640 shares issued and 19,389,967 outstanding at December 31, 2024; 11,204,599 shares issued and 10,612,390 outstanding at December 31, 2023	1,027	583
Additional paid—in capital	423,274	189,027
Retained earnings	126,540	117,667
Accumulated other comprehensive loss	(26,316)	(28,476)
Treasury stock— 332,673 and 592,209 shares, at cost, at December 31, 2024 and 2023, respectively	(7,843)	(13,745)
Total shareholders’ equity	516,682	265,056
Total liabilities and shareholders’ equity	$ 5,441,589	$ 3,064,240